Literature DB >> 25470195

Microbiome: the bacterial tightrope.

Katherine Bourzac.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25470195     DOI： 10.1038/516S14a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.

Authors:  Shin Yoshimoto; Tze Mun Loo; Koji Atarashi; Hiroaki Kanda; Seidai Sato; Seiichi Oyadomari; Yoichiro Iwakura; Kenshiro Oshima; Hidetoshi Morita; Masahira Hattori; Masahisa Hattori; Kenya Honda; Yuichi Ishikawa; Eiji Hara; Naoko Ohtani
Journal:  Nature       Date:  2013-06-26       Impact factor: 49.962

2.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

Authors:  Dianne H Dapito; Ali Mencin; Geum-Youn Gwak; Jean-Philippe Pradere; Myoung-Kuk Jang; Ingmar Mederacke; Jorge M Caviglia; Hossein Khiabanian; Adebowale Adeyemi; Ramon Bataller; Jay H Lefkowitch; Maureen Bower; Richard Friedman; R Balfour Sartor; Raul Rabadan; Robert F Schwabe
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

3.  Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.

Authors:  Maitreyi Raman; Iftikhar Ahmed; Patrick M Gillevet; Chris S Probert; Norman M Ratcliffe; Steve Smith; Rosemary Greenwood; Masoumeh Sikaroodi; Victor Lam; Pam Crotty; Jennifer Bailey; Robert P Myers; Kevin P Rioux
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

4.  Intestinal microbiota in patients with nonalcoholic fatty liver disease.

Authors:  Marialena Mouzaki; Elena M Comelli; Bianca M Arendt; Julia Bonengel; Scott K Fung; Sandra E Fischer; Ian D McGilvray; Johane P Allard
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

5.  Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.

Authors:  J S Bajaj; D M Heuman; P B Hylemon; A J Sanyal; P Puri; R K Sterling; V Luketic; R T Stravitz; M S Siddiqui; M Fuchs; L R Thacker; J B Wade; K Daita; S Sistrun; M B White; N A Noble; C Thorpe; G Kakiyama; W M Pandak; M Sikaroodi; P M Gillevet
Journal:  Aliment Pharmacol Ther       Date:  2014-03-16       Impact factor: 8.171

6.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962
  6 in total
  8 in total

Review 1.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

Review 2.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

Review 3.  A shift in paradigm towards human biology-based systems for cholestatic-liver diseases.

Authors:  Fozia Noor
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

4.  Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation.

Authors:  S Banerjee; G Sindberg; F Wang; J Meng; U Sharma; L Zhang; P Dauer; C Chen; J Dalluge; T Johnson; S Roy
Journal:  Mucosal Immunol       Date:  2016-02-24       Impact factor: 7.313

5.  Regulatory Effect of Resveratrol on Inflammation Induced by Lipopolysaccharides via Reprograming Intestinal Microbes and Ameliorating Serum Metabolism Profiles.

Authors:  Sujuan Ding; Hongmei Jiang; Jun Fang; Gang Liu
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

6.  Antibiotic Disruption of the Gut Microbiota Enhances the Murine Hepatic Dysfunction Associated With a High-Salt Diet.

Authors:  Zheng Zhang; Mengjie Li; Bo Cui; Xiao Chen
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

7.  Lactobacillus rhamnosus Encapsulated in Alginate/Chitosan Microgels Manipulates the Gut Microbiome to Ameliorate Salt-Induced Hepatorenal Injury.

Authors:  Zheng Zhang; Jiajian Liu; Mengjie Li; Binbin Yang; Wei Liu; Zhuangzhuang Chu; Bo Cui; Xiao Chen
Journal:  Front Nutr       Date:  2022-04-14

Review 8.  Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer.

Authors:  Chenchen Bi; Geqiong Xiao; Chunyan Liu; Junwei Yan; Jiaqi Chen; Wenzhang Si; Jian Zhang; Zheng Liu
Journal:  Front Cell Dev Biol       Date:  2021-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.